Why is Aristo Bio-Tech falling/rising?

As of 04-Aug, Aristo Bio-Tech & Lifescience Ltd is currently priced at 122.30, showing no change (0.00%). The stock has underperformed its sector by 1.43% today and has experienced a consecutive fall, with returns remaining flat over the last day. In terms of returns, the stock has seen a decline of 13.87% over the past month and 8.05% year-to-date, although it has increased by 27.73% over the past year. The stock's delivery volume has significantly decreased by 58.33% compared to the 5-day average, indicating falling investor participation, which may contribute to the stock's recent stagnation.
Broader market context shows that while the Sensex has increased by 0.17% over the past week, Aristo Bio-Tech has gained only 0.99%, indicating a weaker performance relative to the benchmark. The stock's performance over the past month has also been notably worse than the Sensex, which has only declined by 2.90%. This underperformance in both short-term and longer-term comparisons suggests that investor sentiment may be cautious, further exacerbated by the declining trading volume and liquidity, which could hinder price recovery.